Why Hasn’t the Carbon 60 Market Blown Up?

Why Hasn’t the Carbon 60 Market Blown Up?

Trace amounts of solvents like toluene or xylene can technically remain in C60 supplements. In fact, the presence of these “hidden” contaminants is one of the primary reasons the C60 market has remained a niche corner of the supplement world rather than a mainstream success.

Here’s the breakdown of why these solvents are there, the risks they pose, and why the market hasn’t “blown up” yet.

1. The “Solvent Problem” in C60 Production

Carbon 60 (Fullerene) is naturally a solid, black, soot-like powder. To make it bioavailable for humans, it must be dissolved into an oil (like olive or avocado oil). However, C60 is notoriously difficult to dissolve.

The Method:

Most C60 is produced using hydrocarbon solvents like toluene, xylene, or benzene to extract and purify the molecules.

The Residual Risk:

If the manufacturer does not use a rigorous vacuum oven drying or high-heat process to remove volatile solvents before mixing the C60 into oil, more than just trace amounts can remain.

The “THF” Scare:

Early studies that claimed C60 was toxic were later found to be flawed because researchers used tetrahydrofuran (THF)—a toxic solvent—to suspend the C60. The toxicity came from the solvent, not the C60 itself. Today, most manufacturers use toluene instead, which is less toxic than THF but still not something you want in a finished product.

2. Why the Market Hasn’t Blown Up

Even with promising early research (like the 2012 Baati study showing lifespan extension in rats), several factors keep C60 from going mainstream:

A. Lack of “Human-Grade” Standardization

Unlike Vitamin C or fish oil, there is no USP (United States Pharmacopeia) standard for C60. This creates a “Wild West” market where:

• 
  “99.9% pure” refers only to fullerene content, not contaminants
  
• 
  Residual solvents are still be present
  
• 
  There are very few long-term human clinical trials
  

B. High Cost of Doing It Right

Producing truly clean, solvent-free C60 is expensive and time-consuming. Many manufacturers rely on solvent-based shortcuts because they’re easier and cheaper.

C. Regulatory Gray Area

Because C60 is considered a nanomaterial, it falls into a complex regulatory category. Larger supplement companies are hesitant to enter the space due to potential future FDA scrutiny.

3. How to Identify a Safer Product

• 
  Look for third-party lab testing
  
• 
  Make sure it includes solvent residue analysis
  
• 
  If a company cannot clearly prove their product is free of residual solvents, that’s a red flag
  

Bottom Line

The C60 market hasn’t blown up because of its own manufacturing challenges—mainly the reliance on solvents and the lack of standardization.

Bottom Line: The C60 market is held back by its own manufacturing hurdles. Until the industry moves away from solvent-based extraction and toward standardized human trials, it will likely remain a "biohacker" secret.

Greska’s Carbon 60 uses no solvents anywhere in the process.